Authors: BJAMASON K SKRUMSAGER BK KIEHR B

Citation: K. Bjamason et al., LEVORMELOXIFENE, A NEW PARTIAL ESTROGEN-RECEPTOR AGONIST DEMONSTRATESANTIRESORPTIVE AND ANTIATHEROGENIC PROPERTIES IN POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 479-479

Authors: SKRUMSAGER BK KIEHR B BJAMASON K

Citation: Bk. Skrumsager et al., LEVORMELOXIFENE - ESCALATING SINGLE ORAL DOSES IN HEALTHY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 480-480

Authors: SKRUMSAGER BK KIEHR B BJAMASON K

Citation: Bk. Skrumsager et al., LEVORMELOXIFENE - SAFETY AND PHARMACOKINETICS AFTER MULTIPLE DOSING OF 56 POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 481-481

Authors: SKRUMSAGER BK CHRISTENSEN JV SNEL S SEIBERLING M

Citation: Bk. Skrumsager et al., TOLERABILITY, SAFETY AND PHARMACOKINETICS OF SINGLE-DOSE AND MULTIPLEDOSING OF THE SELECTIVE D1 ANTAGONIST NNC-01-0687 IN HEALTHY-SUBJECTS, Psychopharmacology, 121(3), 1995, pp. 294-299

Authors: KARLE J CLEMMESEN L HANSEN L ANDERSEN M ANDERSEN J FENSBO C SLOTHNIELSEN M SKRUMSAGER BK LUBLIN H GERLACH J

Citation: J. Karle et al., NNC-01-0687, A SELECTIVE DOPAMINE D1 RECEPTOR ANTAGONIST, IN THE TREATMENT OF SCHIZOPHRENIA, Psychopharmacology, 121(3), 1995, pp. 328-329